• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Re-operations of supratentorial anaplastic astrocytomas.

作者信息

Sipos L, Afra D

机构信息

National Institute of Neurosurgery, Budapest, Hungary.

出版信息

Acta Neurochir (Wien). 1997;139(2):99-104. doi: 10.1007/BF02747187.

DOI:10.1007/BF02747187
PMID:9088366
Abstract

Results of re-operations of 99 adult patients with recurrent supratentorial lobar glioblastomas (60 patients) and anaplastic astrocytomas (39 patients) have been reviewed. In all cases both surgical interventions were performed at the same institute. Age of patients with glioblastoma varied between 19 and 64 and with anaplastic astrocytoma between 21 and 68 years, with a mean value of 48 and 36 years, respectively. The median interval between the first and second operations was 47 weeks for patients with glioblastoma and 83 weeks with anaplastic astrocytoma. The mortality rate of the re-operations was 3%. Following re-operation radio- and/or chemotherapy was applied in most of the cases. Median survival time after re-operation was 18.5 weeks in patients with glioblastoma and 55 weeks with anaplastic astrocytoma. Survival curves were calculated according to Kaplan-Meier method and for statistical evaluation the generalized Wilcoxon test and multiple linear regression method were used. Histologically lower grade tumour at the first operation and longer interval between the two operations proved to influence positively and dedifferentiation of the primary tumour negatively the survival time.

摘要

相似文献

1
Re-operations of supratentorial anaplastic astrocytomas.
Acta Neurochir (Wien). 1997;139(2):99-104. doi: 10.1007/BF02747187.
2
Reoperation for recurrent glioblastoma and anaplastic astrocytoma.复发性胶质母细胞瘤和间变性星形细胞瘤的再次手术
Neurosurgery. 1987 Nov;21(5):615-21. doi: 10.1227/00006123-198711000-00002.
3
The value of reoperation for recurrent glioblastoma.复发性胶质母细胞瘤再次手术的价值。
Can J Surg. 1993 Jun;36(3):271-5.
4
Reoperation for malignant astrocytoma.恶性星形细胞瘤的再次手术
Neurology. 1989 Mar;39(3):430-2. doi: 10.1212/wnl.39.3.430.
5
Development of anaplastic changes in low-grade astrocytomas of childhood.儿童低级别星形细胞瘤间变的发展
Neurosurgery. 1994 Jan;34(1):68-78.
6
BCNU-DBD (Dibromodulcitol) chemotherapy of recurrent supratentorial anaplastic astrocytomas and glioblastomas.卡莫司汀-二溴卫矛醇(DBD,二溴卫矛醇)治疗复发性幕上间变性星形细胞瘤和胶质母细胞瘤
Neoplasma. 2002;49(5):342-5.
7
Reoperation in the treatment of recurrent intracranial malignant gliomas.再次手术治疗复发性颅内恶性胶质瘤。
Neurosurgery. 1987 Nov;21(5):607-14. doi: 10.1227/00006123-198711000-00001.
8
Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas.手术切除范围对幕上胶质母细胞瘤和间变性星形细胞瘤患者生存及生活质量的影响。
Neurosurgery. 1987 Aug;21(2):201-6. doi: 10.1227/00006123-198708000-00012.
9
Histologically confirmed changes on CT of reoperated low-grade astrocytomas.再次手术的低级别星形细胞瘤CT检查的组织学确诊改变。
Neuroradiology. 1997 Nov;39(11):804-10. doi: 10.1007/s002340050509.
10
Superior Efficacy of Gross Total Resection in Anaplastic Astrocytoma Patients Relative to Glioblastoma Patients.间变性星形细胞瘤患者相对于胶质母细胞瘤患者,肿瘤全切除的疗效更优。
World Neurosurg. 2016 Jun;90:186-193. doi: 10.1016/j.wneu.2016.02.078. Epub 2016 Feb 24.

引用本文的文献

1
The impact of intraoperative mapping during re-resection in recurrent gliomas: a systematic review.复发性胶质瘤再次切除术中术中定位的影响:一项系统评价
J Neurooncol. 2025 Feb;171(3):485-493. doi: 10.1007/s11060-024-04874-1. Epub 2024 Nov 18.
2
Stereotactic brachytherapy using iodine 125 seeds for the treatment of primary and recurrent anaplastic glioma WHO° III.使用碘125粒子的立体定向近距离放射治疗原发性和复发性世界卫生组织III级间变性胶质瘤
J Neurooncol. 2016 Oct;130(1):123-131. doi: 10.1007/s11060-016-2214-x. Epub 2016 Jul 15.
3
Novel Surgical Approaches to High-Grade Gliomas.
高级别胶质瘤的新型手术方法
Curr Treat Options Neurol. 2015 Sep;17(9):369. doi: 10.1007/s11940-015-0369-y.
4
The role of cytoreductive surgery in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.细胞减积手术在进展性胶质母细胞瘤治疗中的作用:系统评价和循证临床实践指南。
J Neurooncol. 2014 Jul;118(3):479-88. doi: 10.1007/s11060-013-1336-7. Epub 2014 Apr 23.
5
Safety and efficacy of concomitant chemotherapeutic wafers and iodine-125 seeds for recurrent glioblastoma.化疗薄片与碘-125粒子联合应用于复发性胶质母细胞瘤的安全性和有效性
Surg Neurol Int. 2012;3:137. doi: 10.4103/2152-7806.103644. Epub 2012 Nov 20.
6
Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination.根据 HGG-IMMUNO RPA 模型进行分层可预测接受辅助术后树突细胞疫苗接种的复发性恶性神经胶质瘤患者的结局。
Cancer Immunol Immunother. 2012 Nov;61(11):2105-12. doi: 10.1007/s00262-012-1271-z. Epub 2012 May 8.
7
Treatment of recurrent glioblastoma: can local delivery of mitoxantrone improve survival?复发性胶质母细胞瘤的治疗:米托蒽醌局部给药能否提高生存率?
J Neurooncol. 2008 May;88(1):105-13. doi: 10.1007/s11060-008-9540-6. Epub 2008 Feb 19.
8
Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma.676例新诊断原发性胶质母细胞瘤连续患者生存的预后因素
Neuro Oncol. 2008 Feb;10(1):79-87. doi: 10.1215/15228517-2007-038. Epub 2007 Nov 9.
9
Apoptosis and p53 expression in human gliomas.人类胶质瘤中的细胞凋亡与p53表达
Pathol Oncol Res. 1998;4(4):267-70. doi: 10.1007/BF02905216.